What is NeuroServo?
NeuroServo specializes in cutting-edge electroencephalogram (EEG) technology, engineered to empower hospital medical staff with real-time pathology detection capabilities. The company's core mission is to mitigate the risk of permanent brain damage by enabling swift identification of patient abnormalities, particularly within critical care environments. NeuroServo's innovative solutions address crucial challenges such as seizure confirmation, sedation monitoring, and continuous EEG surveillance, all aimed at enhancing patient outcomes and improving the standard of care for individuals experiencing altered states of consciousness or seizure-related emergencies.
How much funding has NeuroServo raised?
NeuroServo has raised a total of $1.7M across 1 funding round:
Angel/Seed
$1.7M
Angel/Seed (2023): $1.7M with participation from Desjardins Capital, Centre for Aging and Brain Health Innovation, and Investissement Quebec
Key Investors in NeuroServo
Desjardins Capital
Desjardins Capital, through its Capital Croissance PME (CCPME) fund, focuses on investing in small and medium-sized enterprises within Quebec, providing crucial growth capital.
Centre for Aging and Brain Health Innovation
The Centre for Aging and Brain Health Innovation (CABHI) is a dedicated solution accelerator focused on advancing innovations in the aging and brain health sector, supporting companies like NeuroServo through funding and commercialization guidance.
Investissement Quebec
Investissement Quebec is a provincial government agency dedicated to fostering investment and economic development in Quebec, providing businesses with a comprehensive suite of financial solutions to support their growth.
What's next for NeuroServo?
The substantial enterprise-level funding and recent strategic investment signal a new phase of accelerated growth and market penetration for NeuroServo. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand the company's commercial reach within the global healthcare sector. NeuroServo is strategically positioned to become a leader in neurological diagnostics, leveraging its advanced EEG technology to address critical unmet needs in patient monitoring and early intervention.
See full NeuroServo company page
